Receptor tyrosine kinase-like orphan receptor 1 (ROR1) and 2 (ROR2) are receptors for the Wnt5a ligand that have been proposed as potential high-value targets for cancer therapy [5, 6]. The gene discussed is ROR2; the disease is cancer.